Jacobs Levy Equity Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,283,990
| Closed | -$9.78M | – | 963 |
|
|
2022
Q4 | $9.78M | Buy |
1,283,990
+83,912
| +7% | +$639K | 0.07% | 283 |
|
|
2022
Q3 | $11.9M | Buy |
1,200,078
+1,131,993
| +1,663% | +$11.3M | 0.09% | 229 |
|
|
2022
Q2 | $618K | Buy |
+68,085
| New | +$618K | ﹤0.01% | 839 |
|
|
2020
Q4 | – | Sell |
-5,422
| Closed | -$203K | – | 1017 |
|
|
2020
Q3 | $203K | Sell |
5,422
-10,566
| -66% | -$396K | ﹤0.01% | 960 |
|
|
2020
Q2 | $521K | Buy |
+15,988
| New | +$521K | 0.01% | 779 |
|